Skip to content
10-Q

Quarterly Report

Royalty Pharma plc RPRX

0001802768-25-000095

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 562.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 570.16M sh
Shares Diluted Q2 2025 · Jun 30, 2024 596.91M sh
Shares Diluted Q2 2025 · Jun 30, 2024 597.2M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $1B
Stock Repurchased Q2 2025 · Jun 30, 2024 $80M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $960.06M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $1.32B
Long Term Debt Q2 2025 · Jun 30, 2025 $7B
Long Term Debt Q2 2025 · Dec 31, 2024 $6.61B
Short Term Debt Q2 2025 · Jun 30, 2025 $999.44M
Short Term Debt Q2 2025 · Dec 31, 2024 $997.77M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $631.91M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $929.03M
Stockholders Equity Q2 2025 · Jun 30, 2025 $9.5B
Stockholders Equity Q2 2025 · Mar 31, 2025 $9.79B
Stockholders Equity Q2 2025 · Dec 31, 2024 $10.34B
Stockholders Equity Q2 2025 · Jun 30, 2024 $9.75B
Stockholders Equity Q2 2025 · Mar 31, 2024 $9.86B
Stockholders Equity Q2 2025 · Dec 31, 2023 $10.08B
Current Liabilities Q2 2025 · Jun 30, 2025 $1.21B
Current Liabilities Q2 2025 · Dec 31, 2024 $1.25B
Total Liabilities Q2 2025 · Jun 30, 2025 $8.82B
Total Liabilities Q2 2025 · Dec 31, 2024 $7.88B
Current Assets Q2 2025 · Jun 30, 2025 $1.52B
Current Assets Q2 2025 · Dec 31, 2024 $1.8B
Total Assets Q2 2025 · Jun 30, 2025 $18.32B
Total Assets Q2 2025 · Dec 31, 2024 $18.22B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.07
Eps Diluted Q2 2025 · Jun 30, 2025 $0.62
Eps Diluted Q2 2025 · Jun 30, 2024 $0.23
Eps Diluted Q2 2025 · Jun 30, 2024 $0.24
Eps Basic Q2 2025 · Jun 30, 2025 $0.07
Eps Basic Q2 2025 · Jun 30, 2025 $0.63
Eps Basic Q2 2025 · Jun 30, 2024 $0.23
Eps Basic Q2 2025 · Jun 30, 2024 $0.24
Sga Expense Q2 2025 · Jun 30, 2025 $179.77M
Sga Expense Q2 2025 · Jun 30, 2025 $290.48M
Sga Expense Q2 2025 · Jun 30, 2024 $54.71M
Sga Expense Q2 2025 · Jun 30, 2024 $112.36M
Rd Expense Q2 2025 · Jun 30, 2025 $300.5M
Rd Expense Q2 2025 · Jun 30, 2025 $351M
Rd Expense Q2 2025 · Jun 30, 2024 $500K
Rd Expense Q2 2025 · Jun 30, 2024 $1M
Net Income Q2 2025 · Jun 30, 2025 $30.18M
Net Income Q2 2025 · Jun 30, 2025 $268.53M
Net Income Q2 2025 · Jun 30, 2024 $102M
Net Income Q2 2025 · Jun 30, 2024 $106.78M
Operating Income Q2 2025 · Jun 30, 2025 $209.8M
Operating Income Q2 2025 · Jun 30, 2025 $743.98M
Operating Income Q2 2025 · Jun 30, 2024 $269.63M
Operating Income Q2 2025 · Jun 30, 2024 $195.86M
Revenue Q2 2025 · Jun 30, 2025 $578.67M
Revenue Q2 2025 · Jun 30, 2025 $1.15B
Revenue Q2 2025 · Jun 30, 2024 $537.27M
Revenue Q2 2025 · Jun 30, 2024 $1.11B